 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
How Lialda™ Can Help
About Lialda
Lialda is part of a drug class called aminosalicylates, which contain 5-aminosalicylic acid (5-ASA), a well-established drug of choice and often a first-line treatment for the induction of remission in patients with active, mild to moderate ulcerative colitis (UC). Lialda is the first formulation in this class to be approved since 2000.
Lialda contains mesalamine, the active ingredient in other ulcerative colitis medications, and has MMX® Technology.
All other oral mesalamine medications need to be taken 2 to 4 times per day. Lialda is taken just once a day.
A recent survey by the Crohn's and Colitis Foundation of America showed many UC patients had difficulty taking their medication as often as their doctors prescribed. While many of these patients said they simply "forgot" to take their medication, others said they needed to take their medication too many times a day and that their medication was inconvenient.
Lialda my help your loved one achieve remission, controlling the symptoms of UC, with as few as 2 tablets taken once-daily.
Lialda helps reduce flare-ups to achieve remission
To a person with UC, remission can mean living life virtually symptom-free. In clinical trials, people taking Lialda who achieved remission had:
- Less rectal bleeding
- Fewer trips to the bathroom (i.e. fewer bowel movements)
- Reduced inflammation/an improvement in the inside lining of the colon
It's easy to see how once-daily Lialda may help your loved one achieve induction of remission with fewer symptoms.
Tips for Supporting Your Loved One
|
You should not take Lialda if you are allergic to salicylates (including mesalamine or aspirin) or to any of the ingredients of Lialda. Tell your doctor if you have a stomach blockage or are allergic to sulfasalazine. Mesalamine has been associated with a syndrome that may be difficult to distinguish from an ulcerative colitis flare-up. If you experience cramping, abdominal pain, bloody diarrhea, fever, headache or rash, talk to your doctor immediately. Some patients taking mesalamine have reported heart-related hypersensitivity reactions, such as inflammation of the heart muscle and inflammation of the lining of the heart. Tell your doctor if you have problems with your liver or kidneys. In worldwide clinical trials, Lialda was generally well tolerated. The most common adverse events were headache and flatulence. As with other medications, some serious side effects may occur. Less than 1% of patients experienced inflammation of the pancreas, which led to discontinuation of therapy with Lialda. Please see Lialda Full Prescribing Information Privacy Policy | Unsubscribe | For Health Care Professionals
|
